Revised Medicare Prescription Drug Inflation Rebate Program Guidance Clarifies Identification of Rebatable Drugs and Rebates for Drugs in Shortages
December 14, 2023 | |
Revised Medicare Prescription Drug Inflation Rebate Program Guidance Clarifies Identification of Rebatable Drugs and Rebates for Drugs in Shortages
The Centers for Medicare and Medicaid Services (CMS) released revised guidance (Part B Guidance and Part D Guidance) for the Medicare Prescription Drug Inflation Rebate Program (press release, fact sheet). Overall, CMS provides clarity on the identification of rebatable drugs, as well as units to include in the calculation of inflation rebate amounts. The agency also addresses how rebates will… (Slifer, December 14, 2023) #Drug Pricing, #Medicare Part D, #Prescription Drugs
